Harmony Net Invested Capital from 2010 to 2024

HRMY Stock  USD 34.67  1.08  3.02%   
Harmony Biosciences Net Invested Capital yearly trend continues to be fairly stable with very little volatility. Net Invested Capital is likely to outpace its year average in 2024. Net Invested Capital is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. View All Fundamentals
 
Net Invested Capital  
First Reported
2010-12-31
Previous Quarter
660.6 M
Current Value
693.6 M
Quarterly Volatility
390.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 28.4 M, Depreciation And Amortization of 14.7 M or Interest Expense of 17.9 M, as well as many indicators such as Price To Sales Ratio of 3.14, Dividend Yield of 0.0 or PTB Ratio of 4.32. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
Check out the analysis of Harmony Biosciences Correlation against competitors.

Latest Harmony Biosciences' Net Invested Capital Growth Pattern

Below is the plot of the Net Invested Capital of Harmony Biosciences Holdings over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. Harmony Biosciences' Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Harmony Biosciences' overall financial position and show how it may be relating to other accounts over time.
Net Invested Capital10 Years Trend
Slightly volatile
   Net Invested Capital   
       Timeline  

Harmony Net Invested Capital Regression Statistics

Arithmetic Mean7,305,127
Geometric Mean314,036,704
Coefficient Of Variation5,344
Mean Deviation344,269,902
Median(242,673,000)
Standard Deviation390,400,817
Sample Variance152412.8T
Range1B
R-Value0.82
Mean Square Error53349.7T
R-Squared0.67
Significance0.0002
Slope71,719,526
Total Sum of Squares2133779.2T

Harmony Net Invested Capital History

2024693.6 M
2023660.6 M
2022594.5 M
2021378.5 M
2020291.4 M
2019-324.9 M

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' Net Invested Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Invested Capital660.6 M693.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.